RB

Rupam Bajpai

Active Director Director DIN 01869552
DIN 01869552 First appointment Jul 2005 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2005
Shareholding value •••• Premium profile

About Rupam Bajpai

Data last updated:

Rupam Bajpai is a Director at Akcure Biotech Private Limited (since 2005). The company operates in Trading. Akcure Biotech Private Limited reported revenue of ₹1 Lakh (FY 2024).

DIN 01869552
Primary Designation Director
Industry Trading
First Appointment 13 Jul 2005
Oldest Company Age 21 yrs
Largest company Akcure Biotech Private Limited · ₹1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akcure Biotech Private Limited U24232UP2005PTC030353
Director13 Jul 20052005₹1 Lakh (FY 2024)Active

Board colleagues of Rupam Bajpai

NameDINCompanyDesignation
Kapil Bajpai01020764Akcure Biotech Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Akcure Biotech Private Limited
Premium access

Shareholding and investment profile for Rupam Bajpai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupam Bajpai

Rupam Bajpai currently holds 1 directorship: Akcure Biotech Private Limited (Director, since 13 Jul 2005, revenue ₹1 Lakh (FY 2024)).

Rupam Bajpai was first appointed on 13 Jul 2005 as Director at Akcure Biotech Private Limited.

The current boards of Rupam Bajpai's companies include Kapil Bajpai (Akcure Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available